BioRéalités Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 17

Employees

  • Latest Deal Type
  • M&A

BioRéalités General Information

Description

Developer of monoclonal antibodies directed against factors of cancer relapses. The company helps to manage several types of cancer with a focus on colorectal cancer. The company continues to research and help identify a specific abnormal protein that causes colorectal cancer.

Contact Information

Website
www.biorealites.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2040 avenue du Père Soulas
  • 34000 Montpellier
  • France
+33 04
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Servier
Vertical(s)
Oncology
Corporate Office
  • 2040 avenue du Père Soulas
  • 34000 Montpellier
  • France
+33 04

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioRéalités Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 07-Jul-2011 Completed Product Development
2. Early Stage VC 01-Jun-2010 Completed Product Development
1. Early Stage VC 01-Jun-2009 $3.16M $3.16M Completed Product Development
To view BioRéalités’s complete valuation and funding history, request access »

BioRéalités Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

BioRéalités Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2013516437-A Methods for treating colorectal cancer Active 08-Jan-2010
JP-2013516439-A Methods for treating pancreatic cancer Active 08-Jan-2010
JP-2013516617-A Progastrin and liver pathology Active 08-Jan-2010
JP-2013516438-A Methods for treating breast cancer Active 08-Jan-2010
JP-2013507138-A Monoclonal antibody against progastrin and use thereof Active 16-Oct-2009 C07K16/26
To view BioRéalités’s complete patent history, request access »

BioRéalités Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioRéalités Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Soridec Venture Capital Minority
To view BioRéalités’s complete investors history, request access »

Ready to get started?

Request a free trial

BioRéalités FAQs

  • When was BioRéalités founded?

    BioRéalités was founded in 2007.

  • Where is BioRéalités headquartered?

    BioRéalités is headquartered in Montpellier, France.

  • What is the size of BioRéalités?

    BioRéalités has 17 total employees.

  • What industry is BioRéalités in?

    BioRéalités’s primary industry is Biotechnology.

  • Is BioRéalités a private or public company?

    BioRéalités is a Private company.

  • What is BioRéalités’s current revenue?

    The current revenue for BioRéalités is .

  • How much funding has BioRéalités raised over time?

    BioRéalités has raised $4.79M.

  • Who are BioRéalités’s investors?

    Soridec has invested in BioRéalités.

  • When was BioRéalités acquired?

    BioRéalités was acquired on 07-Jul-2011.

  • Who acquired BioRéalités?

    BioRéalités was acquired by Servier.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »